Vimarsana
Biggest News Aggregation in the World

Page 2 - Spherix Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spherix Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spherix Global Today - Breaking & Trending Today

The rise of gastroenterology supergroups - Vimarsana News

The rise of gastroenterology supergroups

"Discover the latest trends in gastroenterology consolidation as management organizations and groups expand, and how private equity is playing a major role in d

Spherix Global Insights Delivers Cheeriodicals to Dialysis - Vimarsana News

Spherix Global Insights Delivers Cheeriodicals to Dialysis

Exton, PA, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Colleagues from Spherix Global Insights partnered with Cheeriodicals to assemble and deliver care packages...

Why gastroenterology is attractive to private equity - Vimarsana News

Why gastroenterology is attractive to private equity

Gastroenterology practices have become increasingly attractive to private equity firms in the past several years, according to a report from University of Michi

Biosimilar Competition Erodes Humira's Market Share; Amjevita Leads the Pack - Vimarsana News

Biosimilar Competition Erodes Humira's Market Share; Amjevita Leads the Pack

A survey of gastroenterologists, dermatologists, and rheumatologists found Amjevita had the most recognition, followed by Cyltezo, the only interchangeable biosimilar on the US market.

Source: ajmc.com
Sanofi (NASDAQ:SNY) Q2 2023 Earnings Call Transcript - Vimarsana News

Sanofi (NASDAQ:SNY) Q2 2023 Earnings Call Transcript

Eva Schaefer-Jansen: Good morning, good afternoon and good evening to everyone. Thank you for joining us to review Sanofi's Second Quarter 2023 Results followed by Q&A session.